Clinical risk management of herb-drug interactions.
The concomitant use of conventional and herbal medicines can lead to clinically relevant herb-drug interactions. Clinical risk management offers a systematic approach to minimize the untoward consequences of these interactions by paying attention to: (i) risk identification and assessment; (ii) development and execution of risk reduction strategies; and (iii) evaluation of risk reduction strategies. This paper reviews which steps should be explored or taken in these domains to improve the clinical risk management of adverse herb-drug interactions.
De Smet
Peter A G M
PA
Scientific Institute of Dutch Pharmacists, The Hague and Department of Clinical Pharmacy, University Medical Centre St Radboud, Nijmegen, the Netherlands. pdesmet@winap.nl
D041743:Herb-Drug Interactions; D006801:Humans; D008517:Phytotherapy / Q000009:adverse effects*; D028321:Plant Preparations / Q000009:adverse effects*; D012307:Risk Factors
D028321:Plant Preparations